Home - AnaptysBio
AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that investigational ANB032, a BTLA …
Pipeline - AnaptysBio
AnaptysBio, Inc. 10770 Wateridge Circle Suite 210 San Diego, CA 92121-5801 (858) 362-6295 (ph) [email protected]
About - AnaptysBio
Enable broad development of our best-in-class programs targeting co-inhibitory receptors in RA and UC.. Generate in vitro and in vivo translational and clinical data to inform the potential …
Science - AnaptysBio
Immune cell modulators are a novel therapeutic class with the potential to deliver differentiated outcomes in autoimmune and inflammatory diseases including dermatology, gastroenterology, …
Working Together to Transform Patient Health - AnaptysBio
If you suspect any fraudulent activity or misrepresentation in connection with an Anaptys job opportunity, please report it to [email protected]. Additionally, you can report any …
Overview - AnaptysBio
Rosnilimab is a novel PD-1 agonist that reduces overactive T cell inflammation. It has two distinct mechanisms of action, depletion and agonism, prevalent both in inflamed tissue and the …
Imsidolimab - AnaptysBio
Imsidolimab is an IgG4 antibody that inhibits the function of the interleukin-36 receptor (IL-36R), a signaling pathway within the immune system shown to be involved in the pathogenesis of …
News - AnaptysBio, Inc.
SAN DIEGO , Jan. 07, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology …
Anaptys Announces Positive Top-Line Phase 3 Clinical
SAN DIEGO, Oct. 09, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, …
Contact - AnaptysBio
AnaptysBio, Inc. 10770 Wateridge Circle Suite 210 San Diego, CA 92121-5801 . Phone: (858) 362-6295 [email protected]